project id: TCGA-UCEC; case submitter id: TCGA-KP-A3W4; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 9.4; age at index: 63; days to birth: -23200; days to death: 554; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1947; year of death: 2011; age at diagnosis: 23200; classification of tumor: not reported; days to diagnosis: 0; figo stage: Stage IIIA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 688; initial weight: 540.0; sample id: 85363534-a7c9-481e-8d37-b961ce1ad7ae; sample submitter id: TCGA-KP-A3W4-01A; portion id: bf924e74-bd28-4560-958d-1cfbcc3f9d57; portion submitter id: TCGA-KP-A3W4-01A-11; slide id: 65b33d84-956f-47aa-bd5f-80912f580e45; slide submitter id: TCGA-KP-A3W4-01A-01-TSA; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;